{
    "nctId": "NCT01133912",
    "briefTitle": "Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb\u00ae) (PGT)",
    "officialTitle": "Phase Ib Study of Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb\u00ae) (PGT) in Patients With HER2 Positive Operable Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 13,
    "primaryOutcomeMeasure": "To evaluate the recommended dose of the combination of paclitaxel, gemcitabine, and lapatinib (Tykerb\u00ae) (PGT) as preoperative chemotherapy in patients with HER2 positive operable breast cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed and newly diagnosed operable breast cancer\n* Documented HER2 positive disease : 3+ overexpression by IHC or HER2 gene amplification by FISH\n* ECOG performance status 0-2\n* Age \u2265 18 years\n* Clinical stage II or III operable breast cancer\n* Axillary node positivity determined by cytology\n* No prior hormonal, chemotherapy, or radiotherapy is allowed\n* No breast operation other than biopsy to make diagnosis is allowed\n* Negative urine pregnancy test within 7 days prior to registration in premenopausal patients\n* Adequate hematopoietic function: Absolute granulocyte count \u22651,500/mm3, platelet \u2265100,000/mm3, hemoglobin \u226510g/mm3\n* Adequate hepatic function: total bilirubin \u22641.5mg/dL, AST/ALT \u22642 x UNL, alkaline phosphatase \u22642 x UNL\n* Adequate renal function: Serum creatinine \u22641.5mg/dL\n* Adequate cardiac function:\n\n  1. Normal or nonspecific EKG taken within 1 month of enrollment\n  2. LVEF \u226550% by MUGA or echocardiogram taken within 4 weeks of enrollment\n* Ability to understand and comply with protocol during study period\n* Patients should sign a written informed consent before study entry\n\nExclusion Criteria:\n\n* Pregnant or lactating women\n* Patients who received hormonal, chemotherapy or radiotherapy for breast cancer\n* Patients with bilateral breast cancer\n* Patients who underwent surgery for breast cancer\n* Patients with node-negative stage IIA (T2N0) breast cancer\n* Patients who have history of cancer other than in situ uterine cervix cancer or nonmelanotic skin cancer\n* Patients with GI tract disease resulting in an inability to take oral medication, malabsorption syndrome, a requirement for IV alimentation, prior surgical procedures affecting absorption, uncontrolled GI disease (e.g., Crohn's disease, ulcerative colitis)",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}